S. Spector

4.3k total citations · 1 hit paper
68 papers, 3.4k citations indexed

About

S. Spector is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, S. Spector has authored 68 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 23 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in S. Spector's work include Neuroscience and Neuropharmacology Research (12 papers), Neuropeptides and Animal Physiology (11 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). S. Spector is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neuropeptides and Animal Physiology (11 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). S. Spector collaborates with scholars based in United States, Germany and China. S. Spector's co-authors include Sidney Udenfriend, Albert Sjoerdsma, James P. Morgan, Barry A. Berkowitz, A. Lévy, S. H. Ngai, J. Hempstead, B.B. Brodie, S Udenfriend and Koichiro Oka and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

S. Spector

67 papers receiving 3.1k citations

Hit Papers

BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-... 1965 2026 1985 2005 1965 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Spector United States 32 1.7k 1.4k 729 311 265 68 3.4k
Morton Levitt United States 22 1.7k 1.0× 1.7k 1.2× 1.0k 1.4× 279 0.9× 237 0.9× 52 4.6k
Jan M. Van Nueten Belgium 28 1.4k 0.8× 1.3k 0.9× 758 1.0× 247 0.8× 407 1.5× 65 3.2k
Bradley V. Clineschmidt United States 32 2.1k 1.3× 1.8k 1.2× 879 1.2× 265 0.9× 303 1.1× 86 3.8k
G. Hertting Germany 30 1.7k 1.0× 1.5k 1.1× 517 0.7× 482 1.5× 325 1.2× 136 3.3k
Jan Häggendal Sweden 28 1.3k 0.8× 1.1k 0.8× 684 0.9× 234 0.8× 372 1.4× 100 3.2k
Motohatsu Fujiwara Japan 31 1.3k 0.8× 2.1k 1.5× 747 1.0× 476 1.5× 321 1.2× 195 4.0k
Aaron H. Anton United States 19 1.1k 0.7× 1.2k 0.8× 573 0.8× 314 1.0× 408 1.5× 36 3.7k
Åke Bertler Sweden 25 1.5k 0.9× 1.0k 0.7× 644 0.9× 262 0.8× 234 0.9× 57 3.6k
Sydney Spector United States 40 2.2k 1.3× 1.8k 1.3× 1.2k 1.7× 472 1.5× 348 1.3× 103 5.4k
Evald Rosengren Sweden 27 1.5k 0.9× 1.1k 0.8× 493 0.7× 205 0.7× 131 0.5× 63 3.6k

Countries citing papers authored by S. Spector

Since Specialization
Citations

This map shows the geographic impact of S. Spector's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Spector with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Spector more than expected).

Fields of papers citing papers by S. Spector

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Spector. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Spector. The network helps show where S. Spector may publish in the future.

Co-authorship network of co-authors of S. Spector

This figure shows the co-authorship network connecting the top 25 collaborators of S. Spector. A scholar is included among the top collaborators of S. Spector based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Spector. S. Spector is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spector, S., et al.. (2001). Endogenous morphine and codeine. Brain Research. 915(2). 155–160. 8 indexed citations
3.
Minna, John D., et al.. (1995). Possible role of endogenous morphine and codeine on growth regulation of lung tissue. Life Sciences. 57(5). 517–521. 11 indexed citations
4.
Stefano, George B., S. Spector, M. Leung, et al.. (1993). Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression.. Proceedings of the National Academy of Sciences. 90(23). 11099–11103. 189 indexed citations
5.
Spector, S., et al.. (1991). Changes of endogenous morphine and codeine contents in the fasting rat.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 647–650. 41 indexed citations
6.
Scott, Meredith, et al.. (1989). Mitral valve reconstruction in the elderly population. The Annals of Thoracic Surgery. 48(2). 213–217. 10 indexed citations
7.
Kodaira, Hiroshi, et al.. (1989). Identification of the convulsant opiate thebaine in mammalian brain.. Proceedings of the National Academy of Sciences. 86(2). 716–719. 25 indexed citations
8.
Morgan, James P., et al.. (1986). Vitamin D3 derivatives inhibit the differentiation of Friend erythroleukemia cells.. Molecular Pharmacology. 30(6). 639–642. 2 indexed citations
9.
Morgan, James P., et al.. (1985). Peripheral-type benzodiazepines influence ornithine decarboxylase levels and neurite outgrowth in PC12 cells.. Proceedings of the National Academy of Sciences. 82(15). 5223–5226. 22 indexed citations
10.
Spector, S.. (1982). Disposition of drugs in man by radioimmunoassay.. Pharmacological Reviews. 34(1). 73–75. 1 indexed citations
11.
Iwatsuki, K, et al.. (1979). Effect of guanethidine on collagen biosynthesis in blood vessels of hypertensive rats.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 240(2). 278–84. 2 indexed citations
12.
Jarrott, Bevyn & S. Spector. (1978). Disposition of clonidine in rats as determined by radioimmunoassay.. Journal of Pharmacology and Experimental Therapeutics. 207(1). 195–202. 35 indexed citations
13.
Spector, S., et al.. (1978). Studies on the monoamine oxidase and catechol-O-methyltransferase of the rat cerebral microvessels.. PubMed. 233(2). 227–34. 24 indexed citations
14.
Blume, Arthur J., et al.. (1977). Binding of the endogenous nonpeptide morphine-like compound to opiate receptors.. Proceedings of the National Academy of Sciences. 74(11). 4927–4931. 31 indexed citations
15.
Lai, F.M. & S. Spector. (1977). BRAIN AND VASCULAR MONOAMINE OXIDASE ACTIVITY IN THE DEOXYCORTICOSTERONE‐SALT HYPERTENSIVE RAT. British Journal of Pharmacology. 59(3). 393–395. 6 indexed citations
16.
Ngai, S. H., A. Lévy, Alfred Finck, Junichi Yano, & S. Spector. (1977). Central nervous system toxicity of hyperbaric oxygen-effects of light, norepinephrine depletion and beta-adrenergic blockade☆. Neuropharmacology. 16(10). 675–679. 8 indexed citations
17.
Kawashima, Kenji, A. Lévy, & S. Spector. (1976). Stereospecific radioimmunoassay for propranolol isomers.. Journal of Pharmacology and Experimental Therapeutics. 196(2). 517–523. 83 indexed citations
18.
Gintzler, Alan R., A. Lévy, & S. Spector. (1976). Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system.. Proceedings of the National Academy of Sciences. 73(6). 2132–2136. 86 indexed citations
19.
O'Brien, R.A., et al.. (1975). Immunopharmacological studies using 5-hydroxytryptamine antibody.. Journal of Pharmacology and Experimental Therapeutics. 194(1). 145–153. 4 indexed citations
20.
Spector, S., Ryo Tabei, Cyrus R. Creveling, et al.. (1968). Reduction of tissue norepinephrine and blood pressure by 3,5-dihydroxy-4-methoxy-phenylalanine. Life Sciences. 7(17). 943–949. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026